Back to Browse Journals

Antibody Technology Journal

Dr Wang

Dr Wang

Editor-in-Chief: Dr Shixia Wang

Shixia Wang, DVM, PhD, is Associate Professor of Medicine at the University of Massachusetts Medical School in Worcester, MA, USA. She received her Doctoral degree in Veterinary Medicine from Hebei Agricultural University and PhD in Microbiology and Immunology from the Chinese Academy of Preventive Medicine, followed by postdoctoral training in viral immunology and DNA vaccine research at the University of Massachusetts Medical School from 1996 to 2000. 

Since 2000, Dr Wang has been a faculty member involved in the research of novel DNA/subunit-based vaccines against HIV, biodefense targets, and emerging infectious diseases including plague, influenza, SARS, and smallpox at the Laboratory of Nucleic Acid Vaccines, Department of Medicine at the University of Massachusetts Medical School.  Recently, her research has focused on the investigation of antibody responses induced by vaccination against various infectious diseases in hosts from small animals to humans, and on the development and characterization of monoclonal antibodies using novel technologies. 

Dr Wang is an author of more than 100 publications including peer-reviewed journal articles and book chapters related to her research on vaccine design/development and vaccine-induced immune responses against various pathogens.  She has been an invited lecturer at medical and scientific meetings in both the United States and China.  She has served as reviewer for medical journals and as a member of Editorial Board for the Advances in Preventive Medicine, and is a member of several medical societies.  Dr Wang has been the Principle Investigator (PI) and co-PI on several research grants supported by NIH/NIAID.

Dr Wang is also an Adjunct Associate Professor at the Cummings School of Veterinary Medicine at Tufts University (Grafton, MA) and an Adjunct Professor at the China-US Vaccine Research Center, Nanjing Medical University (Nanjing, People's Republic of China).

Honorary Editorial Board

Abedelnasser Abulrob, Professor, Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Otawa, ON, Canada

Yasushi Arano, Professor, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan

Ahmad Awada, Professor and Head of the Medical Oncology Clinic, Medicine Department, Jules Bordet Institute, Brussels, Belgium

Ajay K Banga, Professor, Department of Pharmaceutical Sciences, Mercer University, Atlanta, GA, USA

Stefam Barth, Professor of Experimental Medicine and Immunotherapy at the Rheinisch-Westfälische Technische Hochschule, Aachen, Germany

Arun K Bhunia, Professor of Molecular Food Microbiology, Department of Food Science and Department of Comparative Pathobiology, Purdue University, West Lafayette, IN, USA

Mario S Clerici, Professor, Immunology, University of Milano, Milan, Italy

Armando Córdova, Professor in Organic Chemistry, Mid Sweden University, Östersund, Sweden

Zhenqing Feng, Professor, Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Jiangsu, People's Republic of China

Gordon Ferns, Professor of Metabolic Medicine, Faculty of Health, University of Keele, Stoke on Trent, Staffordshire, United Kingdom

Ja-an Annie Ho, Professor, Department of Biological Science and Technology, National Taiwan University, Taipei, Taiwan

Jennifer LS Knaack, Department of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, Mercer University, Atlanta, GA, USA

Maciej Lesniak, Professor of Surgery and Cancer Biology, The University of Chicago Hospitals, Chicago, IL, USA

Torben Moos, Professor, Neurobiology, Aalborg University, Aalborg, Denmark

Massimo Morbidelli, Professor,Chemical Reaction Engineering, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland

James L Murray, Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Suresh R Naik, Professor & Head of Pharmacology Department, Sinhgad Institute of Pharmaceutical Sciences, Lonavala Campus, Maharashtra, India

Hideo Ohkawa, Professor, Faculty of Life Science and Biotechnology, Fukuyama University, Hiroshima, Japan

Luciano Polonelli, Professor, Microbiology and Clinical Microbiology, University of Parma, Parma, Italy

Professor, Department of Craniofacial Biology, Medical University of South Carolina, Charleston, SC, USA

Teruna J Siahaan, Professor, Pharmaceutical Chemistry Department, The University of Kansas, Lawrence, KS, USA

Fritz Sörgel, Professor at the School of Medicine at the University of Essen, Essen, Germany

William R Strohl, Vice President and Head, Biologics Research, J&J Biotechnology Center of Excellence, New Brunswick, NJ, USA

Dar-Fu Tai, Professor, Department of Chemistry, National Dong-Hwa University, Hualien, Taiwan

Desmond J. Tobin, Professor of Cell Biology, School of Life Sciences, University of Bradford, West Yorkshire, United Kingdom

Ashiwel Simon Undieh, Professor in Neuroscience, Pharmacology, and Pharmaceutical Sciences, and Chairman of the Department of Pharmaceutical Sciences, Thomas Jefferson University, Philadelphia, PA, USA

Suresh P Vyas, Professor of Pharmaceutical Biotechnology, Department of Pharmaceutical Sciences, Dr HS Gour University, Sagar, India

Fan Wang, Professor of Radiology, Director, Medical Isotopes Research Center, Peking University, Beijing, People's Republic of China

Heinz Wiendl, Professor of Neurology, Department of Inflammatory Diseases of the Nervous System and Neurooncology, University Hospital Muenster, Muenster, Germany

Xueguang Zhang, Professor, Immunology, Soochow University, Suzhou, People's Republic of China

Ping Zhou, Professor and Vice Director, Institute of Transplantation, Tongji Hospital, HuaZhong University of Science and Technology, Wuhan, People's Republic of China

Xiangdong Zhu, Professor, Department of Physics, University of California, Davis, CA, USA